What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1566352

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1566352

Prostaglandin Analogs Market Size, Share, Trends, Industry Analysis Report: By Route of Administration, By Drug Type, By Application, By Distribution Channel, and By Region - Market Forecast, 2024 - 2032

PUBLISHED: September 1, 2024

PAGES: 115 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The global prostaglandin analogs market size is expected to reach USD 6,566.71 million by 2032, according to a new study by Polaris Market Research. The report "Prostaglandin Analogs Market Size, Share, Trends, Industry Analysis Report: By Route of Administration (Topical, Oral, and Injectable), By Drug Type, By Application, By Distribution Channel, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The prostaglandin analogs market is a significant segment within the pharmaceutical industry, primarily driven by their role in managing glaucoma. These medications, including Latanoprost, Bimatoprost, and Travoprost, are widely used as the first-line treatment for lowering intraocular pressure (IOP), a critical factor in controlling glaucoma. Their market dominance is attributed to their proven efficacy and favorable safety profile, which have made them the preferred choice for long-term glaucoma management.

Several key factors contribute to the growth of the prostaglandin analogs market. The high prevalence of glaucoma, a leading cause of irreversible blindness, necessitates effective and reliable treatment options. Prostaglandin analogs address this need by significantly reducing IOP and helping prevent vision loss. Additionally, the continuous advancement in drug formulations and delivery systems enhances patient compliance and therapeutic outcomes. Ongoing clinical research into new formulations and combinations further supports market growth by offering improved efficacy and safety profiles.

Overall, the prostaglandin analogs market is driven by the urgent need for effective glaucoma treatments, ongoing innovations, and a growing patient population requiring long-term care.

Prostaglandin Analogs Market Report Highlights:

Latanoprost dominates the prostaglandin analogs market due to its proven efficacy in lowering intraocular pressure in glaucoma patients, making it the most widely prescribed drug within this category.

Topical administration leads the market as it offers targeted treatment with fewer systemic side effects, particularly in the management of ocular conditions such as glaucoma and ocular hypertension.

Glaucoma Treatment is the largest segment, driven by the increasing global prevalence of glaucoma and the effectiveness of prostaglandin analogs in reducing intraocular pressure.

Hospital Pharmacies hold the largest market share, benefiting from the trust in hospital-based dispensing and the availability of specialized ophthalmic treatments.

North America dominates the prostaglandin analogs market, attributed to advanced healthcare infrastructure and a high prevalence of eye disorders. The Asia Pacific is also the fastest-growing region, fueled by increasing healthcare investments, a growing elderly population, and rising awareness about glaucoma and its treatment options.

Polaris Market Research has segmented the prostaglandin analogs market report based on drug type, route of administration, application, distribution channel, and region

Prostaglandin Analogs - Drug Type Outlook (Revenue - USD million, 2019 - 2032)

Latanoprost
Bimatoprost
Travoprost
Tafluprost
Others

Prostaglandin Analogs - Route of Administration Outlook (Revenue - USD million, 2019 - 2032)

Topical
Oral
Injectable

Prostaglandin Analogs - Application Outlook (Revenue - USD million, 2019 - 2032)

Glaucoma Treatment
Labor Induction
Erectile Dysfunction
Gastric Protection
Others

Prostaglandin Analogs - Distribution Channel Outlook (Revenue - USD million, 2019 - 2032)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Prostaglandin Analogs - Regional Outlook (Revenue - USD million, 2019 - 2032)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM5052

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Prostaglandin Analogs Market Insights

4.1. Prostaglandin Analogs Market -Snapshot
4.2. Prostaglandin Analogs Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Ophthalmic Conditions
  - 4.2.1.2. Advancements in Drug Formulations and Delivery Systems
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Cost and Accessibility are hindering the Prostaglandin Analogs market growth
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Prostaglandin Analogs Market Route of Administration Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Prostaglandin Analogs Market, by Drug Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
5.3. Latanoprost
- 5.3.1. Global Prostaglandin Analogs Market, by Latanoprost, by Region, 2019-2032 (USD million)
5.4. Bimatoprost
- 5.4.1. Global Prostaglandin Analogs Market, by Bimatoprost, by Region, 2019-2032 (USD million)
5.5. Travoprost
- 5.5.1. Global Prostaglandin Analogs Market, by Travoprost, by Region, 2019-2032 (USD million)
5.6. Tafluprost
- 5.6.1. Global Prostaglandin Analogs Market, by Tafluprost, by Region, 2019-2032 (USD million)
5.7. Others
- 5.7.1. Global Prostaglandin Analogs Market, by Others, by Region, 2019-2032 (USD million)

6. Global Prostaglandin Analogs Market, Route of Administration

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
6.3. Topical
- 6.3.1. Global Prostaglandin Analogs Market, by Topical, by Region, 2019-2032 (USD million)
6.4. Oral
- 6.4.1. Global Prostaglandin Analogs Market, by Oral, by Region, 2019-2032 (USD million)
6.5. Injectable
- 6.5.1. Global Prostaglandin Analogs Market, by Injectable, by Region, 2019-2032 (USD million)

7. Global Prostaglandin Analogs Market, by Application

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
7.3. Glaucoma Treatment
- 7.3.1. Global Prostaglandin Analogs Market, by Glaucoma Treatment, by Region, 2019-2032 (USD million)
7.4. Labor Induction
- 7.4.1. Global Prostaglandin Analogs Market, by Labor Induction, by Region, 2019-2032 (USD million)
7.5. Erectile Dysfunction
- 7.5.1. Global Prostaglandin Analogs Market, by Erectile Dysfunction, by Region, 2019-2032 (USD million)
7.6. Gastric Protection
- 7.6.1. Global Prostaglandin Analogs Market, by Gastric Protection, by Region, 2019-2032 (USD million)
7.7. Others
- 7.7.1. Global Prostaglandin Analogs Market, by Others, by Region, 2019-2032 (USD million)

8. Global Prostaglandin Analogs Market, by Distribution Channel

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
8.3. Hospital Pharmacies
- 8.3.1. Global Prostaglandin Analogs Market, by Hospital Pharmacies, by Region, 2019-2032 (USD million)
8.4. Retail Pharmacies
- 8.4.1. Global Prostaglandin Analogs Market, by Retail Pharmacies, by Region, 2019-2032 (USD million)
8.5. Online Pharmacies
- 8.5.1. Global Prostaglandin Analogs Market, by Online Pharmacies, by Region, 2019-2032 (USD million)

9. Global Prostaglandin Analogs Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Prostaglandin Analogs Market Assessment, By Geography, 2019-2032 (USD million)
9.3. Prostaglandin Analogs Market - North America
- 9.3.1. North America: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
- 9.3.2. North America: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
- 9.3.3. North America: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
- 9.3.4. North America: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.3.5. Prostaglandin Analogs Market - U.S.
  - 9.3.5.1. U.S.: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.3.5.2. U.S.: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.3.5.3. U.S.: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.3.5.4. U.S.: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.3.6. Prostaglandin Analogs Market - Canada
  - 9.3.6.1. Canada: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.3.6.2. Canada: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.3.6.3. Canada: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.3.6.4. Canada: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
9.4. Prostaglandin Analogs Market - Europe
- 9.4.1. Europe: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
- 9.4.2. Europe: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
- 9.4.3. Europe: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
- 9.4.4. Europe: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.4.5. Prostaglandin Analogs Market - UK
  - 9.4.5.1. UK: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.4.5.2. UK: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.4.5.3. UK: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.4.5.4. UK: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.4.6. Prostaglandin Analogs Market - France
  - 9.4.6.1. France: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.4.6.2. France: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.4.6.3. France: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.4.6.4. France: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.4.7. Prostaglandin Analogs Market - Germany
  - 9.4.7.1. Germany: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.4.7.2. Germany: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.4.7.3. Germany: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.4.7.4. Germany: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.4.8. Prostaglandin Analogs Market - Italy
  - 9.4.8.1. Italy: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.4.8.2. Italy: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.4.8.3. Italy: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.4.8.4. Italy: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.4.9. Prostaglandin Analogs Market - Spain
  - 9.4.9.1. Spain: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.4.9.2. Spain: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.4.9.3. Spain: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.4.9.4. Spain: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.4.10. Prostaglandin Analogs Market - Netherlands
  - 9.4.10.1. Netherlands: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.4.10.2. Netherlands: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.4.10.3. Netherlands: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.4.10.4. Netherlands: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.4.11. Prostaglandin Analogs Market - Russia
  - 9.4.11.1. Russia: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.4.11.2. Russia: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.4.11.3. Russia: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.4.11.4. Russia: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.4.12. Prostaglandin Analogs Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.4.12.2. Rest of Europe: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.4.12.3. Rest of Europe: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.4.12.4. Rest of Europe: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
9.5. Prostaglandin Analogs Market - Asia Pacific
- 9.5.1. Asia Pacific: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
- 9.5.2. Asia Pacific: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
- 9.5.3. Asia Pacific: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
- 9.5.4. Asia Pacific: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.5.5. Prostaglandin Analogs Market - China
  - 9.5.5.1. China: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.5.5.2. China: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.5.5.3. China: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.5.5.4. China: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.5.6. Prostaglandin Analogs Market - India
  - 9.5.6.1. India: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.5.6.2. India: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.5.6.3. India: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.5.6.4. India: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.5.7. Prostaglandin Analogs Market - Malaysia
  - 9.5.7.1. Malaysia: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.5.7.2. Malaysia: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.5.7.3. Malaysia: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.5.7.4. Malaysia: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.5.8. Prostaglandin Analogs Market - Japan
  - 9.5.8.1. Japan: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.5.8.2. Japan: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.5.8.3. Japan: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.5.8.4. Japan: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.5.9. Prostaglandin Analogs Market - Indonesia
  - 9.5.9.1. Indonesia: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.5.9.2. Indonesia: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.5.9.3. Indonesia: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.5.9.4. Indonesia: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.5.10. Prostaglandin Analogs Market - South Korea
  - 9.5.10.1. South Korea: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.5.10.2. South Korea: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.5.10.3. South Korea: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.5.10.4. South Korea: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.5.11. Prostaglandin Analogs Market - Australia
  - 9.5.11.1. Australia: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.5.11.2. Australia: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.5.11.3. Australia: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.5.11.4. Australia: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.5.12. Prostaglandin Analogs Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.5.12.2. Rest of Asia Pacific: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.5.12.3. Rest of Asia Pacific: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.5.12.4. Rest of Asia Pacific: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
9.6. Prostaglandin Analogs Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
- 9.6.2. Middle East & Africa: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
- 9.6.3. Middle East & Africa: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
- 9.6.4. Middle East & Africa: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.6.5. Prostaglandin Analogs Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.6.5.2. Saudi Arabia: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.6.5.3. Saudi Arabia: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.6.5.4. Saudi Arabia: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.6.6. Prostaglandin Analogs Market - UAE
  - 9.6.6.1. UAE: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.6.6.2. UAE: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.6.6.3. UAE: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.6.6.4. UAE: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.6.7. Prostaglandin Analogs Market - Israel
  - 9.6.7.1. Israel: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.6.7.2. Israel: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.6.7.3. Israel: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.6.7.4. Israel: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.6.8. Prostaglandin Analogs Market - South Africa
  - 9.6.8.1. South Africa: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.6.8.2. South Africa: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.6.8.3. South Africa: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.6.8.4. South Africa: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.6.9. Prostaglandin Analogs Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.6.9.2. Rest of Middle East & Africa: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.6.9.3. Rest of Middle East & Africa: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.6.9.4. Rest of Middle East & Africa: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
9.7. Prostaglandin Analogs Market - Latin America
- 9.7.1. Latin America: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
- 9.7.2. Latin America: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
- 9.7.3. Latin America: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
- 9.7.4. Latin America: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.7.5. Prostaglandin Analogs Market - Mexico
  - 9.7.5.1. Mexico: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.7.5.2. Mexico: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.7.5.3. Mexico: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.7.5.4. Mexico: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.7.6. Prostaglandin Analogs Market - Brazil
  - 9.7.6.1. Brazil: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.7.6.2. Brazil: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.7.6.3. Brazil: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.7.6.4. Brazil: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.7.7. Prostaglandin Analogs Market - Argentina
  - 9.7.7.1. Argentina: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.7.7.2. Argentina: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.7.7.3. Argentina: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.7.7.4. Argentina: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
- 9.7.8. Prostaglandin Analogs Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
  - 9.7.8.2. Rest of Latin America: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
  - 9.7.8.3. Rest of Latin America: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
  - 9.7.8.4. Rest of Latin America: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Pfizer Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Per Distribution Channel
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Allergan (an AbbVie company)
- 11.2.1. Company Overview
- 11.2.2. Financial Per Distribution Channel
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Novartis AG
- 11.3.1. Company Overview
- 11.3.2. Financial Per Distribution Channel
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Bayer AG
- 11.4.1. Company Overview
- 11.4.2. Financial Per Distribution Channel
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. GlaxoSmithKline plc
- 11.5.1. Company Overview
- 11.5.2. Financial Per Distribution Channel
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Merck & Co., Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Per Distribution Channel
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Santen Pharmaceutical Co., Ltd.
- 11.7.1. Company Overview
- 11.7.2. Financial Per Distribution Channel
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Ocular Therapeutix, Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Per Distribution Channel
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Aerie Pharmaceuticals, Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Per Distribution Channel
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Sun Pharmaceutical Industries Ltd.
- 11.10.1. Company Overview
- 11.10.2. Financial Per Distribution Channel
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Lupin Pharmaceuticals, Inc.
- 11.11.1. Company Overview
- 11.11.2. Financial Per Distribution Channel
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Teva Pharmaceutical Industries Ltd.
- 11.12.1. Company Overview
- 11.12.2. Financial Per Distribution Channel
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Hikma Pharmaceuticals PLC
- 11.13.1. Company Overview
- 11.13.2. Financial Per Distribution Channel
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Mylan N.V.
- 11.14.1. Company Overview
- 11.14.2. Financial Per Distribution Channel
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development

Product Code: PM5052

List of Tables

Table 1 Global Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 2 Global Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 3 Global Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 4 Global Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 5 North America: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 6 North America: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 7 North America: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 8 North America: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 9 U.S.: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 10 U.S.: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 11 U.S.: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 12 U.S.: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 13 Canada: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 14 Canada: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 15 Canada: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 16 Canada: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 17 Europe: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 18 Europe: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 19 Europe: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 20 Europe: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 21 UK: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 22 UK: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 23 UK: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 24 UK: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 25 France: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 26 France: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 27 France: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 28 France: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 29 Germany: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 30 Germany: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 31 Germany: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 32 Germany: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 33 Italy: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 34 Italy: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 35 Italy: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 36 Italy: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 37 Spain: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 38 Spain: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 39 Spain: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 40 Spain: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 41 Netherlands: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 42 Netherlands: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 43 Netherlands: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 44 Netherlands: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 45 Russia: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 46 Russia: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 47 Russia: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 48 Russia: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 49 Rest of Europe: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 50 Rest of Europe: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 51 Rest of Europe: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 52 Rest of Europe: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 53 Asia Pacific: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 54 Asia Pacific: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 55 Asia Pacific: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 56 Asia Pacific: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 57 China: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 58 China: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 59 China: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 60 China: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 61 India: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 62 India: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 63 India: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 64 India: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 65 Malaysia: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 66 Malaysia: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 67 Malaysia: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 68 Malaysia: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 69 Japan: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 70 Japan: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 71 Japan: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 72 Japan: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 73 Indonesia: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 74 Indonesia: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 75 Indonesia: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 76 Indonesia: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 77 South Korea: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 78 South Korea: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 79 South Korea: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 80 South Korea: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 81 Australia: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 82 Australia: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 83 Australia: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 84 Australia: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 85 Rest of Asia Pacific: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 86 Rest of Asia Pacific: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 87 Rest of Asia Pacific: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 88 Rest of Asia Pacific: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 89 Middle East & Africa: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 90 Middle East & Africa: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 91 Middle East & Africa: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 92 Middle East & Africa: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 93 Saudi Arabia: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 94 Saudi Arabia: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 95 Saudi Arabia: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 96 Saudi Arabia: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 97 UAE: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 98 UAE: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 99 UAE: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 100 UAE: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 101 Israel: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 102 Israel: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 103 Israel: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 104 Israel: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 105 South Africa: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 106 South Africa: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 107 South Africa: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 108 South Africa: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 109 Rest of Middle East & Africa: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 110 Rest of Middle East & Africa: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 111 Rest of Middle East & Africa: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 112 Rest of Middle East & Africa: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 113 Latin America: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 114 Latin America: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 115 Latin America: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 116 Latin America: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 117 Mexico: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 118 Mexico: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 119 Mexico: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 120 Mexico: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 121 Brazil: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 122 Brazil: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 123 Brazil: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 124 Brazil: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 125 Argentina: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 126 Argentina: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 127 Argentina: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 128 Argentina: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)
Table 129 Rest of Latin America: Prostaglandin Analogs Market, by Drug Type, 2019-2032 (USD million)
Table 130 Rest of Latin America: Prostaglandin Analogs Market, by Route of Administration, 2019-2032 (USD million)
Table 131 Rest of Latin America: Prostaglandin Analogs Market, by Application, 2019-2032 (USD million)
Table 132 Rest of Latin America: Prostaglandin Analogs Market, by Distribution Channel, 2019-2032 (USD million)

List of Figures

Figure 1. Global Prostaglandin Analogs Market, 2019-2032 (USD million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Drug Type
Figure 7. Global Prostaglandin Analogs Market, by Drug Type, 2023 & 2032 (USD million)
Figure 8. Global Prostaglandin Analogs Market, by Route of Administration, 2023 & 2032 (USD million)
Figure 9. Global Prostaglandin Analogs Market, by Application, 2023 & 2032 (USD million)
Figure 10. Global Prostaglandin Analogs Market, by Distribution Channel, 2023 & 2032 (USD million)